Amlodipine And Valsartan
Product Images NDC 45865-890

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 45865-890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (890)

This is a product description for the medication Amlodipine & Valsartan available in tablet form with a strength of 5/320mg. The tablets serve as a generic alternative for a medication called Exforge. The text also includes a manufacturer's name, Srurobiido Pharla TD, and a warning not to take the medication if not prescribed by a physician.*

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Amlo Val Fig1)

FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Amlo Val Fig2)

This is a graph showing the probability of achieving Diastolic Blood Pressure (DBP) lower than 90 mmHg at Week 8 with Amiodipine and Valsartan Tablets at 10 mg/320 mg. The graph includes baseline DBP values ranging from 100 to 110 mmHg. There is also a mention of Valsartan 320 mg, Amiodipine 10 mg, and placebo.*

FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Amlo Val Fig3)

This document appears to be a medical report showing a chart with the probability of achieving a systolic blood pressure of less than 130 mmHg after taking Amlodipine and Valsartan tablets that contain 10mg Amiodipine and 320mg Valsartan. The chart is based on a baseline systolic blood pressure measurement taken at Week 8. There is also a placebo listed in the ingredients but no additional information is available.*

FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Amlo Val Fig4)

The text describes a graph showing the probability of achieving a diastolic blood pressure of less than 80 mmHg at week 8 for a combination of Amlodipine and Valsartan tablets with 10mg and 320mg doses respectively, compared to a placebo. The graph shows baseline DBP values of 100, 105, and 110 and has no other discernible information.*

FDA Label Image

Chemical Structure1 (Amlo Val Str1)

FDA Label Image

Chemical Structure2 (Amlo Val Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.